share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:拟议出售证券
美股sec公告 ·  05/10 10:14
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 05/10/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $3,214.08, were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement, which was compensation from the issuer. This upcoming transaction follows a significant trading activity by Austin over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $276,005. The notice of the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 05/10/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $3,214.08, were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement, which was compensation from the issuer. This upcoming transaction follows a significant trading activity by Austin over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $276,005. The notice of the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
正如在最近的一份文件中宣布的那样,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年10月5日出售3,968股A类股票。这些股票的总市值为3,214.08美元,最初是在2022年7月10日作为限制性股票归属协议的一部分收购的,该协议是发行人的补偿。这笔即将进行的交易是在奥斯汀在过去三个月中进行了大量交易活动之后进行的,共出售了246,016股股票,总收益约为276,005美元。计划出售的通知与出售的同一天提交,该交易的计划已于2023年3月14日获得通过。
正如在最近的一份文件中宣布的那样,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年10月5日出售3,968股A类股票。这些股票的总市值为3,214.08美元,最初是在2022年7月10日作为限制性股票归属协议的一部分收购的,该协议是发行人的补偿。这笔即将进行的交易是在奥斯汀在过去三个月中进行了大量交易活动之后进行的,共出售了246,016股股票,总收益约为276,005美元。计划出售的通知与出售的同一天提交,该交易的计划已于2023年3月14日获得通过。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息